Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Bernard Malavaud

Showing results (1-10 of 157) with videos related to

Pageof 16
Sort By:
European Urology|July 1, 2008
Editorial comment on: prostate-specific antigen kinetics in clinical decision-making during active surveillance for early prostate cancer--a reviewBernard Malavaud
European Urology|March 26, 2004
T1G3 bladder tumours: the case for radical cystectomyBernard Malavaud
Nature Reviews. Urology|May 6, 2015
Prostate cancer: Can image-guided biopsy findings evaluate risk of ECE?Daniel Portalez, Bernard Malavaud
Cancer Research|April 23, 2009
When the sphingosine kinase 1/sphingosine 1-phosphate pathway meets hypoxia signaling: new targets for cancer therapyIsabelle Ader, Bernard Malavaud, Olivier Cuvillier
Histopathology|October 7, 2018
Comment on "Prognostic pathological factors in radical cystectomy after neoadjuvant chemotherapy"Bernard Malavaud, Gwendoline Daniel, Marie-Laure Ranty
The Lancet. Oncology|October 5, 2023
Combination therapy with olaparib and abiraterone acetate for metastatic castration-resistant prostate cancerAlberto Martini, Giuseppe Fallara, Guillaume Ploussard, et al.
Radiology|April 15, 2020
Closing the Gap between Prostate Cancer and Deep Learning Detection ToolsOlivier Meyrignac, Richard Aziza, Mathieu Roumiguie, et al.
Biochemical and Biophysical Research Communications|November 26, 2009
Sphingosine kinase-1 mediates androgen-induced osteoblast cell growthClaire Martin, Jean-Michel Lafosse, Bernard Malavaud, et al.
Progres En Urologie : Journal De L'Association Francaise D'Urologie Et De La Societe Francaise D'Urologie|July 27, 2007
[Role of 150 mg bicalutamide in the treatment of prostate cancer: 3rd analysis of the EPC (early prostate cancer) program]Richard-Olivier Fourcade, Pierre Richaud, Patrick Coloby, et al.
Cancer Research|October 17, 2008
Sphingosine kinase 1: a new modulator of hypoxia inducible factor 1alpha during hypoxia in human cancer cellsIsabelle Ader, Leyre Brizuela, Pierre Bouquerel, et al.
Pageof 16

Showing results (1-10 of 157) with videos related to

Sort By:
Pageof 16
European Urology|July 1, 2008
Editorial comment on: prostate-specific antigen kinetics in clinical decision-making during active surveillance for early prostate cancer--a reviewBernard Malavaud
European Urology|March 26, 2004
T1G3 bladder tumours: the case for radical cystectomyBernard Malavaud
Nature Reviews. Urology|May 6, 2015
Prostate cancer: Can image-guided biopsy findings evaluate risk of ECE?Daniel Portalez, Bernard Malavaud
Cancer Research|April 23, 2009
When the sphingosine kinase 1/sphingosine 1-phosphate pathway meets hypoxia signaling: new targets for cancer therapyIsabelle Ader, Bernard Malavaud, Olivier Cuvillier
Histopathology|October 7, 2018
Comment on "Prognostic pathological factors in radical cystectomy after neoadjuvant chemotherapy"Bernard Malavaud, Gwendoline Daniel, Marie-Laure Ranty
The Lancet. Oncology|October 5, 2023
Combination therapy with olaparib and abiraterone acetate for metastatic castration-resistant prostate cancerAlberto Martini, Giuseppe Fallara, Guillaume Ploussard, et al.
Radiology|April 15, 2020
Closing the Gap between Prostate Cancer and Deep Learning Detection ToolsOlivier Meyrignac, Richard Aziza, Mathieu Roumiguie, et al.
Biochemical and Biophysical Research Communications|November 26, 2009
Sphingosine kinase-1 mediates androgen-induced osteoblast cell growthClaire Martin, Jean-Michel Lafosse, Bernard Malavaud, et al.
Progres En Urologie : Journal De L'Association Francaise D'Urologie Et De La Societe Francaise D'Urologie|July 27, 2007
[Role of 150 mg bicalutamide in the treatment of prostate cancer: 3rd analysis of the EPC (early prostate cancer) program]Richard-Olivier Fourcade, Pierre Richaud, Patrick Coloby, et al.
Cancer Research|October 17, 2008
Sphingosine kinase 1: a new modulator of hypoxia inducible factor 1alpha during hypoxia in human cancer cellsIsabelle Ader, Leyre Brizuela, Pierre Bouquerel, et al.
Pageof 16